Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.10
-0.01 (-0.14%)
At close: Apr 17, 2026

HKG:2566 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
138.6119.7859.87119.41
Depreciation & Amortization
36.2235.8235.7724.24
Other Amortization
0.720.32--
Loss (Gain) From Sale of Assets
0.270.410.040.33
Loss (Gain) From Sale of Investments
6.51.220.46-0.08
Stock-Based Compensation
5.311.930.180.15
Other Operating Activities
26.2426.6212.747.24
Change in Accounts Receivable
-144.3-62.47-82.03-131.24
Change in Inventory
11.390.9127.7949.16
Change in Accounts Payable
-15.42-9.22-14.8-32.69
Change in Unearned Revenue
7.59-2.15-5.031.19
Change in Other Net Operating Assets
21.6812.61-12.4129.83
Operating Cash Flow
94.79135.7722.5667.53
Operating Cash Flow Growth
-30.19%501.82%-66.59%-
Capital Expenditures
-15.09-21.1-23.3-53.94
Sale of Property, Plant & Equipment
0.1200.010.05
Sale (Purchase) of Intangibles
-64.76-25.88-35.66-8.97
Investing Cash Flow
-79.73-46.98-58.94-62.86
Long-Term Debt Issued
130.2143.31204.17209.62
Long-Term Debt Repaid
-176.55-196.16-170.3-158.65
Net Debt Issued (Repaid)
-46.35-52.8633.8850.97
Issuance of Common Stock
521---
Common Dividends Paid
---12-
Other Financing Activities
-46.34-14.49-8.98-9.75
Financing Cash Flow
428.32-67.3512.8941.23
Foreign Exchange Rate Adjustments
1.080.210.2-0.12
Net Cash Flow
444.4521.64-23.2945.78
Free Cash Flow
79.69114.66-0.7413.59
Free Cash Flow Growth
-30.50%---
Free Cash Flow Margin
5.82%8.91%-0.07%1.04%
Free Cash Flow Per Share
0.390.57-0.000.07
Cash Interest Paid
7.159.418.989.75
Cash Income Tax Paid
19.16-1.1-10.511.74
Levered Free Cash Flow
14.9112.11-51.21-
Unlevered Free Cash Flow
19.3717.98-45.56-
Change in Working Capital
-119.06-60.32-86.5-83.76
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.